Mi Tang

ORCID：0000-0001-7284-6097

发表论文 30 篇 · 总被引 252 次 · h-index 9

代表论文

• SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models (2019 · Acta Pharmacologica Sinica · 被引 45)
• CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone (2016 · Scientific Reports · 被引 35)
• The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury (2023 · Scientific Reports · 被引 25)
• Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysis (2022 · The International Journal of Biological Markers · 被引 25)
• Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies (2019 · Molecular Cancer Therapeutics · 被引 18)
• The progress of peptide vaccine clinical trials in gynecologic oncology (2022 · Human Vaccines & Immunotherapeutics · 被引 17)